Edition:
United Kingdom

GNI Group Ltd (2160.T)

2160.T on Tokyo Stock Exchange

552JPY
22 Nov 2017
Change (% chg)

¥2 (+0.36%)
Prev Close
¥550
Open
¥551
Day's High
¥556
Day's Low
¥537
Volume
4,638,000
Avg. Vol
6,898,295
52-wk High
¥938
52-wk Low
¥172

Chart for

About

GNI Group Ltd. is a Japan-based company engaged in the drug discovery activities that utilize biotechnologies. The Company is engaged in the development of therapeutic agents for diseases that have many sufferers in Asian countries such as Japan and China, as well as clinical trial and bio-verification test businesses. The... (more)
No analyst recommendations are available for .

Overall

Beta: 1.42
Market Cap(Mil.): ¥56,246.84
Shares Outstanding(Mil.): 134.56
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 89.23 16.44
EPS (TTM): -- -- --
ROI: -- 2.53 10.62
ROE: -- 3.17 14.20

BRIEF-GNI Group unit receives marketing approval for Bi-Ostetic Bioactive Glass Foam related product

* Says unit Berkeley Advanced Biomaterials receives marketing approval for Bi-Ostetic Bioactive Glass Foam related product in U.S. from FDA

31 Oct 2017

BRIEF-GNI Group gets IND clearance by FDA for liver fibrosis treatment

* GNI Group announces clearance of investigational new drug (IND) by FDA for F351 clinical trials in the treatment of liver fibrosis

09 Oct 2017

BRIEF- GNI Group unit says clearance of IND by FDA for F351 clinical trials in the treatment of liver fibrosis

* Says its wholly-owned subsidiary GNI USA, Inc had received U.S. FDA clearance on Sept. 29 (U.S. local time) for the Investigational New Drug application (IND) for F351 for U.S. clinical trials in the treatment of liver fibrosis

02 Oct 2017

BRIEF-GNI Group says exercise of options

* Says 4,082 units of its 40th series options were exercised to 4.1 million shares of its common stock, from July 3 to July 18

18 Jul 2017

BRIEF- GNI Group unit GNI USA to sell stake in IriSys for $3.8 mln and GNI Group to acquire stake in GNI-EPS (HONG KONG) HOLDINGS for $4.2 mln

* Says its wholly owned unit GNI USA, Inc will sell 242,029 voting rights in IriSys, LLC to EPS Americas, Corp., for $3.8 million (425.2 million yen), on July 31, and will cut voting power in IriSys, LLC to 15 percent from 35 percent

30 Jun 2017

BRIEF-GNI Group says exercise of options

* Says 2,102 units of its 40th series options were exercised to 2,102,000 shares of its common stock from June 15 to June 20

20 Jun 2017

BRIEF-GNI Group says exercise of options

* Says 5,909 units of its 40th series options were exercised to 5.9 million shares of its common stock, from June 13 to June 14

14 Jun 2017

BRIEF- GNI Group announces exercise of options

* Says 2,196 units of its 40th series options were exercised to 2.2 million shares of its common stock from June 5 to June 12

12 Jun 2017

BRIEF- GNI Group announces exercise of options

* Says 2,055 units of its 40th series options were exercised to 2.1 million shares of its common stock on June 1 and June 2

02 Jun 2017

BRIEF-GNI Group announces exercise of options

* Says 2,536 of its 40th series options were exercised to 2.5 million shares, during period from May 9 to May 25

25 May 2017

Earnings vs. Estimates